We aim to provide a neurocognitive account of communicative disabilities in patients with autism spectrum disorder (ASD), focussing on shared representations of a communicative context. We expect that ASD patients show impaired shared…
ID
Source
Brief title
Condition
- Communication disorders and disturbances
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. Differences in communicative success (percentage correct) and behavioral
communicative alignment (correspondence in communicative signals between
successive interactions) between ASD patients and NT and high-SA controls;
2. Differences in neural communicative alignment (cerebral coherence) between
ASD patients and NT and high-SA controls;
3. Between-group differences in successful communicative meaning interpretation
(percentage correct); different eye-gaze pattern trajectories and different
patterns of brain activity associated communicative meaning interpretation;
4. Spatial overlap in neural communicative alignment in the nonverbal and
verbal tasks, and potential between-group differences;
5. Differences in communicative adjustment between ASD patients and NT and
high-SA controls as assessed with an online communication game, and whether
communicative adjustment is associated with increased grey matter volume in the
prefrontal cortex.
6. EEG will be used to provide a fine-grained temporal and spectral
characterization of communicative alignment and context-dependent
interpretation; and potential between-group differences.
Secondary outcome
1. Answers to various questionnaires (see section 8.3.3) will be used to
examine potential associations between the main study outcomes and individual
differences in autism and social anxiety symptom severity, (verbal) IQ,
alexithymia, social reward sensitivity and demographics (also in the NT
controls only).
2. Eye-tracking: we will investigate differences in eye gaze pattern and pupil
dilation during task performance (TCG and neuro-CSI) between ASD patients and
NT and high-SA controls, and whether this is associated with our main study
outcomes.
3. MR-spectroscopy: we will investigate differences in the
excitatory-inhibitory balance of the rSTG between ASD patients and NT and
high-SA controls, and whether this is associated with our main study outcomes.
4. EEG-fMRI: Investigate whether potential differences in rSTG BOLD activity
during communicative alignment are related to differences in
electrophysiological activity of the rSTG, as measured with EEG.
5. EEG-study: Investigate how ASD patients process multimodal communicative
signs embedded in communicative settings, in particular whether they benefit
from the use of co-speech gestures used by the speaker in the same way as
high-SA and NT controls.
Background summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, characterized
by deficits in social interaction and communication. Deficits in communication
are most evident in social situations where literal meaning and the speaker*s
intention strongly diverge, such as in the case of irony and sarcasm (Tesink et
al, 2009; Zalla et al, 2014). Understanding communication deficits in ASD may
ultimately result in new targets for interventions aimed at improving social
communication in ASD patients. Surprisingly, however, communication deficits in
ASD have rarely been studied during live interactions. Furthermore, when
investigating communication deficits in ASD, it is important to take social
anxiety into account, which is prevalent in ASD, influences social abilities
and could be a particularly strong confound when investigating live social
interactions (as in this study).
Recent evidence suggest that humans understand each other because they
continuously develop and coordinate a shared conceptual space that provides
context to select and interpret their communicative behaviours. Here, we aim to
investigate whether ASD patients have difficulties in using the conceptual
space defined by an ongoing interaction to resolve the pervasive ambiguity of
human communicative signals.
Study objective
We aim to provide a neurocognitive account of communicative disabilities in
patients with autism spectrum disorder (ASD), focussing on shared
representations of a communicative context. We expect that ASD patients show
impaired shared representations of a communicative context compared to NT and
high socially anxious (SA) controls.
Study design
In this crossesctional study, 52 patients with autism spectrum disorder (ASD),
52 high-SA controls and 52 healthy participants will participate in two fMRI
sessions. As we are interested in social interactions, we will invite 2
participants to simulataneously participate in the study and play a
communication game during fMRI scanning (dual-fMRI). Differences in
communicative succes and alignment between pairs of ASD patients, pairs of SAD
patients and pairs of healthy participants will be investigated.
It has been shown that social experience shapes people*s social abilities
(Stolk, Hunnius, Bekkering, & Toni, 2013). The high-SA group will provide a
control for potentially reduced social experience in autism as a consequence of
avoiding social interactions throughout life.
After completion of the cross-sectional fMRI study, participants will be
reinvited at the DCCN to participate in thea follow-up EEG-study at the DCCN
(optional). EEG measures the brain potentials generated by the brain and is not
harmful for the participants. The EEG study will also consist of two sessions,
each taking one hour, in which participants perform similar communicative tasks
as in the fMRI study. We will again offer the possibility to our participants
to schedule the second EEG-session on a separate day.
Study burden and risks
All participants will be invited to the lab for two fMRI scanning sessions,
during which they will perform two well-established communication tasks. fMRI
scanning is not harmful for the participants. All procedures described in this
protocol are well established, carry negligible risk, and constitute a minimal
burden for the participants. Additionally, we offer the possibility to our
participants to schedule the second fMRI scanning session on a different day.
To further minimize participants* burden, we will administer a battery of
questionnaires online, allowing participants to fill out these questionnaire at
home at a convenient time. No pharmacological or otherwise invasive
interventions are applied. The EEG-procedures are also safe, well establised,
carry negligible risk and consistute minimal burden for the participants.
Kapittelweg 29
Nijmegen 5625 EN
NL
Kapittelweg 29
Nijmegen 5625 EN
NL
Listed location countries
Age
Inclusion criteria
- Between 18 and 40 years of age
- Normal or corrected-to-normal vision
- Normal uncorrected hearing
- Eligibility for MRI (i.e. no metals in or around the body, metal fragments,
pacemakers, claustrophobia)
- Body mass index between 18.5 and 30
- Willingness and ability to give written informed consent and willingness and
ability to understand the nature and content, to participate and to comply with
the study requirements.
- Education level MBO-4 or higher
- Capable to read and comprehend the Dutch language
ASD patients:
- Current ASD diagnosis
Exclusion criteria
- Current alcohol or drug abuse
- Use of psychotropic medication or systemic glucocorticoids
- History of neurological disorders (e.g., traumatic brain injury, seizure
history)
- Any severe or chronic systemic disease
- Severe cognitive impairment or a history of organic mental disorder
- Use of recreational drugs over a period of 72 hours prior to MRI scanning,
and use of alcohol within the last 24 hours before MRI scanning
- History of neurological treatment or current neurological treatment
- History of head surgery
- Claustrophobia
- Epilepsy
- Pregnancy
- Dyslexia
All patients:
- Current psychotic, bipolar, substance-related, severe personality disorder,
or mental retardation
- Current severe depressive disorder
- Prominent current suicidal risk or homicidal ideation
ASD patients:
- Current SAD diagnosis
High-socially anxious (SA) individuals:
- Current ASD diagnosis
Neurotypical participants:
- (lifetime history of) ASD or SAD diagnosis
- Current DSM-5 axis 1 disorder
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL72420.091.19 |